Genentech Competitors and Similar CompaniesClear all
Genentech's competitors and similar companies include Allergan, Opthea and Biogen.
 Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products. |  Opthea Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 1976 | Founding Date 1948 | Founding Date 2012 | Founding Date 1978 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Public |
Tags | ||||
Locations | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more | Locations South Yarra, AU HQ Toorak, AU | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 18,077 | Employees 10,5471% decrease | Employees 33 | Employees 7,605 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 711.2 m | Valuation ($) 26.7 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $25k (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $146k (FY, 2025) | Gross profit $7.5b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($162.8m) (FY, 2025) | Net income $1.3b (FY, 2025) |
Operating ⚠ | ||||
Phase I Trials Products | Phase I Trials Products 28 (Jul, 2025) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 4 (FY, 2024) |
Phase II Trials Products | Phase II Trials Products 19 (Jul, 2025) | Phase II Trials Products N/A | Phase II Trials Products 2 (FY, 2020) | Phase II Trials Products 6 (FY, 2024) |
Phase III Trials Products | Phase III Trials Products 41 (Jul, 2025) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Allergan
HQ
Dublin, IE
Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products.
View companyOpthea
HQ
South Yarra, AU
Employees
33
Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company